TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker

Erica L. Mayer, Vandana G. Abramson, Rachel C. Jankowitz, Carla I. Falkson, P. Kelly Marcom, Tiffany A. Traina, Lisa A. Carey, Mothaffar F. Rimawi, Jennifer M. Specht, Kathy D. Miller, Vered Stearns, Nadine Tung, Charles M. Perou, Andrea L. Richardson, Kathryn P. Componeschi, Lorenzo Trippa, Zhenying Tan‐Wasielewski, Kirsten M. Timms, Ian E. Krop, Antonio C. Wolff, Eric P. Winer